A Pragmatic Trial of a 6-Month Strategy for Rifampicin-Resistant Tuberculosis
New England Journal of Medicine · 25.06.2026 · 394 (24) · 2429-2439
DOI: 10.1056/nejmoa2503687 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift New England Journal of Medicine, erschienen am 25.06.2026. Verfasst von Francesca Conradie und 11 weiteren Autor:innen. Beteiligte Einrichtung: Isango Lethemba TB Research Unit, University of the Witwatersrand, Gqeberha, South Africa. Hauptthemen laut MEDLINE: Antitubercular Agents, Mycobacterium tuberculosis, Tuberculosis, Multidrug-Resistant, Tuberculosis, Pulmonary. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: United States Agency for International Development.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Isango Lethemba TB Research Unit, University of the Witwatersrand, Gqeberha, South Africa.
- Clinical HIV Research Unit, University of the Witwatersrand, Johannesburg.
- Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
- Department of Medicine, University of Cape Town, Cape Town, South Africa.
- Queen Mary and Barts Health Tuberculosis Centre, Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London.
- Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Förderung
- United States Agency for International Development
Zitieren
APA
Conradie, F., Badat, T., Poswa, A., Rajaram, S., Kooverjee, S., Maartens, G., Meintjes, G., Hughes, J., Schaaf, H. S., Howell, P., Ndjeka, N., & Phillips, P. P. J. (2026). A Pragmatic Trial of a 6-Month Strategy for Rifampicin-Resistant Tuberculosis. New England Journal of Medicine, 394(24), 2429-2439. https://doi.org/10.1056/nejmoa2503687
Vancouver
Conradie F, Badat T, Poswa A, Rajaram S, Kooverjee S, Maartens G, et al. A Pragmatic Trial of a 6-Month Strategy for Rifampicin-Resistant Tuberculosis. New England Journal of Medicine. 2026;394(24):2429-2439. doi:10.1056/nejmoa2503687
BibTeX
@article{Conradie2026,
author = {Conradie, Francesca and Badat, Tasnim and Poswa, Asanda and Rajaram, Shakira and Kooverjee, Shaneen and Maartens, Gary and Meintjes, Graeme and Hughes, Jennifer and Schaaf, H Simon and Howell, Pauline and Ndjeka, Norbert and Phillips, Patrick P J},
title = {A Pragmatic Trial of a 6-Month Strategy for Rifampicin-Resistant Tuberculosis},
journal = {New England Journal of Medicine},
year = {2026},
volume = {394},
number = {24},
pages = {2429--2439},
doi = {10.1056/nejmoa2503687}
}
EUVIMED